John Friend Mahoney
John Friend Mahoney (August 1, 1889 – February 23, 1957) was an American physician and medical researcher who made significant contributions to the field of medicine, particularly in the treatment of syphilis. He is best known for his pioneering work in the development and implementation of penicillin as a treatment for syphilis, which revolutionized the management of the disease.
Early Life and Education[edit | edit source]
John Friend Mahoney was born on August 1, 1889, in Fond du Lac, Wisconsin. He pursued his medical education at the University of Notre Dame and later at the University of Pennsylvania, where he earned his medical degree in 1914.
Career[edit | edit source]
Mahoney began his career in the United States Public Health Service (USPHS) in 1917. During his tenure, he held various positions and conducted extensive research in the field of infectious diseases. His most notable work was conducted at the United States Marine Hospital in Staten Island, New York.
Penicillin and Syphilis[edit | edit source]
In the early 1940s, Mahoney and his colleagues conducted groundbreaking research on the use of penicillin to treat syphilis. Prior to this, the standard treatment for syphilis involved the use of arsenic-based compounds, which were often toxic and less effective. Mahoney's research demonstrated that penicillin was a highly effective and safe treatment for syphilis, leading to its widespread adoption and significantly reducing the prevalence of the disease.
Later Life and Legacy[edit | edit source]
After his retirement from the USPHS in 1948, Mahoney continued to contribute to the field of medicine through his work with various medical organizations. He received numerous awards and honors for his contributions, including the Lasker-DeBakey Clinical Medical Research Award in 1946.
John Friend Mahoney passed away on February 23, 1957, leaving behind a legacy of innovation and dedication to improving public health.
Related Pages[edit | edit source]
- Syphilis
- Penicillin
- United States Public Health Service
- Lasker-DeBakey Clinical Medical Research Award
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
